Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes. (4th February 2022)

• Record Type: Journal Article
• Authors: Rosenstein, Igal; Andersen, Oluf; Victor, Daniel; Englund, Elisabet; Granberg, Tobias; Hedberg‐Oldfors, Carola; Jood, Katarina; Fitrah, Yusran Ady; Ikeuchi, Takeshi; Danylaité Karrenbauer, Virginija
• Is Part Of: Acta neurologica Scandinavica. Volume 145:Number 5(2022)
• Page Start: 599
• Page End: 609
• Publication Date: 2022-02-04
• Subjects: adult‐onset leukoencephalopathy with spheroids and pigmented glia -- biomarkers -- colony stimulating factor 1 receptor -- CSF1R gene -- neurodegeneration -- primary microgliopathy; Neurology -- Periodicals; 616.8
• DOI: 10.1111/ane.13589
• Languages: English
• ISSNs: 0001-6314

Abstract

Abstract: Colony stimulating factor 1 receptor (CSF1R)‐related leukoencephalopathy is a rare, genetic disease caused by heterozygous mutations in the CSF1R gene with rapidly progressive neurodegeneration, behavioral, cognitive, motor disturbances. Objective: To describe four cases of CSF1R ‐related leukoencephalopathy from three families with two different pathogenic mutations in the tyrosine kinase domain of CSF1R and to develop an integrated presentation of inter‐individual diversity of clinical presentations. Methods: This is an observational study of a case series. Patients diagnosed with CSF1R encephalopathy were evaluated with standardized functional estimation scores and subject to analysis of cerebrospinal fluid biomarkers. Brain computed tomography (CT) and magnetic resonance imaging (MRI) were evaluated. We performed a functional phosphorylation assay to confirm the dysfunction of mutated CSF1R protein. Results: Two heterozygous missense mutations in the CSF1R gene were identified, c.2344C>T; p.Arg777Trp and c.2329C>T; p.Arg782Cys. A phosphorylation assay in vitro showed markedly reduced autophosphorylation in cells expressing mutations. According to ACMG criteria, both mutations were pathogenic. A radiological investigation revealed typical white matter lesions in all cases. There was inter‐individual diversity in the loss of cognitive, motor‐neuronal, and extrapyramidal functions. Conclusions: Including the present cases, currently three CSF1R mutations are known in Sweden. We present a visualization tool to describe the clinical diversity, with potential use for longitudinal follow‐up for this and other leukoencephalopathies.